高尿酸血症与肾脏病、高血压及心血管疾病:NKF科学研讨会报告
美国国家肾脏基金会(NKF)于2016年9月召开科学研讨会,综述细胞培养、动物模型、流行病学、孟德尔随机化及小型临床试验证据,评估血清尿酸升高与肾脏病、高血压、糖尿病及心血管疾病的关系。总体结论认为尿酸与上述疾病的相关性及因果性尚不确定,需进一步研究。
要点
- 血清尿酸升高与肾脏病、高血压、糖尿病相关,但因果性证据不一致。
- 孟德尔随机化研究多不支持尿酸对肾脏病、高血压或糖尿病的因果作用。
- 小型降尿酸治疗试验结果不一,设计局限且效力不足。
核心结论
- 尿酸是痛风、肾结石及肿瘤溶解综合征所致急性肾损伤的病因,但其与肾脏病、心血管疾病及糖尿病的关系仍有争议。
- 尿酸是否在肾脏和心血管疾病中具有因果作用尚需进一步研究。
研究设计与样本
- 美国国家肾脏基金会于2016年9月组织召开科学研讨会,综述当前证据。
主要发现
- 细胞培养研究和动物模型提示血清尿酸浓度升高可能促进肾脏病、高血压和代谢综合征。
- 流行病学证据支持血清尿酸浓度升高是肾脏病、高血压和糖尿病发生的危险因素,但方法学差异及肾功能细微变化对尿酸浓度的影响使结论不确定。
- 孟德尔随机化研究通常不支持血清尿酸在肾脏病、高血压或糖尿病中的因果作用,但人群非均质性、未考虑环境交互及对基因多态性影响尿酸相关生物学机制理解不足使解读复杂。
- 若干小型临床试验提示降尿酸治疗对肾功能、血压和胰岛素抵抗有益,但其他试验为阴性,许多试验存在设计局限和效力不足。
临床怎么用
- 临床需认识到血清尿酸升高与肾脏病、高血压及糖尿病的关联证据不一致,不宜仅凭尿酸水平推断因果。
- 降尿酸治疗对肾脏和心血管结局的获益证据尚不充分,决策应结合个体情况并参考进一步研究结果。
局限性
- 流行病学研究存在方法学差异,且肾功能细微变化即可影响血清尿酸浓度,使结论不确定。
- 孟德尔随机化研究受人群非均质性、未考虑环境交互及对基因多态性生物学机制理解不足的限制。
- 许多临床试验存在设计局限和效力不足,部分试验结果为阴性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Urate is a cause of gout, kidney stones, and acute kidney injury from tumor lysis syndrome, but its relationship to kidney disease, cardiovascular disease, and diabetes remains controversial. A scientific workshop organized by the National Kidney Foundation was held in September 2016 to review current evidence. Cell culture studies and animal models suggest that elevated serum urate concentrations can contribute to kidney disease, hypertension, and metabolic syndrome. Epidemiologic evidence also supports elevated serum urate concentrations as a risk factor for the development of kidney disease, hypertension, and diabetes, but differences in methodologies and inpacts on serum urate concentrations by even subtle changes in kidney function render conclusions uncertain. Mendelian randomization studies generally do not support a causal role of serum urate in kidney disease, hypertension, or diabetes, although interpretation is complicated by nonhomogeneous populations, a failure to consider environmental interactions, and a lack of understanding of how the genetic polymorphisms affect biological mechanisms related to urate. Although several small clinical trials suggest benefits of urate-lowering therapies on kidney function, blood pressure, and insulin resistance, others have been negative, with many trials having design limitations and insufficient power. Thus, whether uric acid has a causal role in kidney and cardiovascular diseases requires further study.
引用
- Johnson RJ, Bakris GL, Borghi C, et al. Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation. Am J Kidney Dis. 2018. PMID: 29496260. doi:10.1053/j.ajkd.2017.12.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。